CVR number 37837334
Industry 869500

Østerbro Fysioterapi ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.7% 5.1% 2.6% 2.5% 3.2%  
Credit score (0-100)  36 42 61 61 56  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  5,278 7,666 8,172 9,160 8,570  
EBITDA  -744 387 701 2,612 2,267  
EBIT  -1,158 39.6 345 2,217 1,763  
Pre-tax profit (PTP)  -1,172.8 4.3 315.8 2,084.4 1,571.8  
Net earnings  -926.2 3.4 242.2 1,620.2 1,218.0  
Pre-tax profit without non-rec. items  -1,173 4.3 316 2,084 1,572  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  166 119 116 515 747  
Shareholders equity total  3,028 3,031 3,273 2,044 1,537  
Interest-bearing liabilities  491 466 567 2,002 2,623  
Balance sheet total (assets)  5,559 5,263 5,538 6,215 5,686  
Net Debt  489 462 565 1,450 2,622  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,278 7,666 8,172 9,160 8,570  
Gross profit growth  -5.4% 45.2% 6.6% 12.1% -6.4%  
Employees  13 15 15 14 17  
Employee growth %  18.2% 15.4% 0.0% -6.7% 21.4%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,559 5,263 5,538 6,215 5,686  
Balance sheet change%  -14.2% -5.3% 5.2% 12.2% -8.5%  
Added value  -744.3 386.5 700.9 2,572.9 2,266.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,350 -694 -659 -297 -572  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -21.9% 0.5% 4.2% 24.2% 20.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -19.2% 0.7% 6.4% 37.7% 29.6%  
ROI %  -21.8% 0.9% 7.4% 46.4% 35.8%  
ROE %  -24.9% 0.1% 7.7% 60.9% 68.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  54.5% 57.6% 59.1% 32.9% 27.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -65.8% 119.5% 80.6% 55.5% 115.7%  
Gearing %  16.2% 15.4% 17.3% 98.0% 170.7%  
Net interest  0 0 0 0 0  
Financing costs %  3.8% 7.4% 5.7% 10.4% 8.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.4 0.8 1.5 1.2  
Current Ratio  0.4 0.5 1.0 1.6 1.4  
Cash and cash equivalent  1.2 3.9 1.8 552.5 1.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -907.5 -563.4 9.8 662.5 355.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -57 26 47 184 133  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -57 26 47 187 133  
EBIT / employee  -89 3 23 158 104  
Net earnings / employee  -71 0 16 116 72